Vertex Pharmaceuticals Inc (VRTX) Com Stk
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Annual & interim reports are not available for this stock.
Financial results for the last 5 years
Values are quoted in the stock's local currency: US dollar.
Income Statement: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
---|---|---|---|---|---|
$ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | |
Revenue: | 9,869.20 | 8,930.70 | 7,574.40 | 6,205.70 | 4,162.82 |
Operating Profit / (Loss): | 3,832.00 | 4,307.40 | 2,782.10 | 2,856.30 | 1,197.57 |
Net Interest: | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax: | 4,379.80 | 4,232.40 | 2,730.40 | 3,116.90 | 1,394.92 |
Profit after tax from continuing operations: | 3,619.60 | 3,322.00 | 2,342.10 | 2,711.70 | 1,176.81 |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | n/a | n/a | n/a | n/a | n/a |
Attributable to: | |||||
Equity holders of parent company: | n/a | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | 1,405.00¢ | 1,297.00¢ | 909.00¢ | 1,044.00¢ | 458.00¢ |
Diluted: | n/a | n/a | n/a | n/a | n/a |
Adjusted: | 1,405.00¢ | 1,297.00¢ | 909.00¢ | 1,029.00¢ | 458.00¢ |
Dividend per Share: | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
$ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | |
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | 1,452.90 | 1,455.80 | 1,424.40 | 958.50 | 745.08 |
Intangible Assets: | 1,927.90 | 1,691.60 | 1,402.20 | 1,402.20 | 1,402.16 |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets: | 0.00 | 0.00 | 0.00 | n/a | n/a |
Other Non-Current Assets: | 5,205.20 | 1,768.70 | 3,457.80 | n/a | 1,348.40 |
8,586.00 | 4,916.10 | 6,284.40 | 2,360.70 | 3,495.64 | |
Current Assets: | |||||
Inventories: | 738.80 | 460.60 | 353.10 | 280.80 | 167.50 |
Trade and Other Receivables: | n/a | n/a | n/a | n/a | n/a |
Cash at Bank & In Hand: | 10,369.10 | 10,504.00 | 6,795.00 | 6,658.90 | 3,109.32 |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | 3,036.30 | 2,270.20 | n/a | 2,451.40 | 1,546.01 |
14,144.20 | 13,234.80 | 7,148.10 | 9,391.10 | 4,822.83 | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | 22,730.20 | 18,150.90 | 13,432.50 | 11,751.80 | 8,318.46 |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities: | 3,547.40 | 2,742.10 | 2,142.00 | n/a | 1,334.83 |
3,547.40 | 2,742.10 | 2,142.00 | n/a | 1,334.83 | |
Net Current Assets: | c 10,596.80 | c 10,492.70 | c 5,006.10 | c 9,391.10 | c 3,488.00 |
Non-Current Liabilities: | |||||
Borrowings: | 724.70 | 810.30 | 887.20 | 581.50 | 538.58 |
Provisions: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Liabilities: | 877.70 | 685.80 | 303.30 | 2,483.50 | 359.82 |
1,602.40 | 1,496.10 | 1,190.50 | 3,065.00 | 898.39 | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | 5,149.80 | 4,238.20 | 3,332.50 | 3,065.00 | 2,233.22 |
Net Assets: | 17,580.40 | 13,912.70 | 10,100.00 | 8,686.80 | 6,085.24 |
Capital & reserves: | |||||
Share Capital: | n/a | n/a | n/a | n/a | n/a |
Share Premium Account: | n/a | n/a | n/a | n/a | n/a |
Other Reserves: | n/a | n/a | n/a | n/a | n/a |
Retained Earnings: | n/a | n/a | n/a | n/a | n/a |
Shareholders Funds: | 17,580.40 | 13,912.70 | 10,100.00 | 8,686.80 | 6,085.24 |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | 17,580.40 | 13,912.70 | 10,100.00 | 8,686.80 | 6,085.24 |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.